🇺🇸 FDA

Company profile · Sponsor

Menarini

Menarini International Operations Luxembourg S.A. (MIOL)

E0642B9 · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Menarini (E0642B9) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E0642B9
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. Nilemdo 180 mg film-coated tablets, Obicetrapib, Obicetrapib matching placebo, Bempedoic acid matching placebo

    Menarini

    Dyslipidemia at High to Very High Cardiovascular Risk

    phase 3 small molecule active

    1 trial

  2. Vaborem 1 g/1 g powder for concentrate for solution for infusion

    Menarini

    Suspected or confirmed Gram negative infections

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Menarini?

Menarini (E0642B9) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Menarini sponsor?

We track 2 ClinicalTrials.gov-linked programs for Menarini, including Nilemdo 180 mg film-coated tablets, Obicetrapib, Obicetrapib matching placebo, Bempedoic acid matching placebo and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Menarini company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.